Virios Therapeutics (VIRI) Tops Q2 EPS by 7c

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Goldman's Garrett sees investors dialing back tech exposure into H2
• General Mills (GIS) PT Lowered to $42 at Freedom Broker